WHO concerned about COVID-19 impact on indigenous?people in the Americas

20 July 2020

Health?UN

With the Americas still the epicentre of the COVID-19 pandemic, the impact on the region’s?indigenous people is of deep concern, the World Health Organization (WHO) said on Monday.

indigenous adj. /?n?d?d??n?s/ 本地的；當(dāng)?shù)氐?；土生土長的

More than 70,000 cases and over 2,000 deaths were reported among this population as of 6 July, according to the UN agency.

There have been at least six cases among the?Nahua people, who live in the Peruvian?Amazon, latest information has revealed.

Nahua?/'nɑ:w?/n. (Nahua) （美）納瓦（人名）??Peruvian/p??ru?vi?n/ 秘魯?shù)?/span>

A vulnerable population

WHO?chief Tedros Adhanom Ghebreyesus explained that because indigenous people are among the world’s poorest and most vulnerable groups, they are especially at risk of contracting?the disease.

Contract：我們常見的是作名詞使用，合同，合約，作動詞時除了我們常見的簽訂合同，締結(jié)聯(lián)盟的意思外，還有比較少遇見的：

1.?to become less or smaller; to make sth become less or smaller （使）收縮，縮小

?Glass contracts as it cools. 玻璃遇冷收縮。 ?a contracting market 萎縮的市場

2. ( medical 醫(yī) ) to get an illness 感染（疾?。坏茫ú。?/span>

?to contract AIDS/a virus/a disease 感染艾滋病╱病毒╱疾

“Like other vulnerable groups, indigenous peoples face many challenges.? This includes a lack of political representation, economic marginalization?and lack of access to health, education and social services”, he?said, speaking from Geneva during the regular crisis update.

marginalization /?mɑ?d??n?la??ze??n/邊緣化，排斥，忽略

“Indigenous peoples often have a high burden of poverty, unemployment, malnutrition and both communicable and non-communicable diseases, making them more vulnerable to?COVID-19?and its severe outcomes.”

malnutrition n. /?m?lnju??tr??n/ 營養(yǎng)不良

communicable and non-communicable diseases：傳染性疾病和非傳染性疾病

Stepping up?action

step up ：增加?? He urged donors to step up their efforts to send aid to Somalia. 他敦促捐贈者再接再厲，將救援物資送往索馬里。

WHO’s Regional Office for the Americas recently published recommendations for preventing and responding to COVID-19 among indigenous peoples.

The agency also is working with the Coordinator of Indigenous Organizations of the Amazon River Basin, to step up?the fight against the disease.

river basin 江河流域; 河流盆地

Lessons learned from Ebola

Ebola /?i?b??l?/ 埃博拉病毒

WHO also used the briefing to underline?the importance of contact tracing to suppress COVID-19 transmission among indigenous communities and the population at large.

Underline：以前文章遇到很多次，還有它的同義詞underscore 強調(diào)，下劃線

The process is essential as more countries begin to re-open after lifting lockdown measures.

“One of the lessons from the recent Ebola outbreak in the eastern Democratic Republic of the Congo, which was declared over the last month, is that contact tracing?can be done even in the most difficult circumstances, with security problems”, Tedros told journalists.

Democratic Republic of the Congo：剛果共和國??contact tracing：接觸者追蹤

Dr Ibrahima Socé Fall, WHO Assistant Director-General for Emergency Response, said contact tracing helps break further transmission of COVID-19, thus reducing its caseload?and impact.

Caseload：以前文章也寫過幾次，待處理的案件數(shù)量

“What we need to understand is that contact tracing is not an isolated practice. It is part of the best practices for epidemiology,” he said, speaking in French.

epidemiology n. /?ep??di?mi??l?d?i/ ?流行病學(xué)

Experimental vaccine ‘good news’

WHO has welcomed promising news about a potential vaccine against COVID-19, as research into treatments in multiple countries, continues.

An experimental vaccine developed by Oxford University and the pharmaceutical company AstraZeneca, appears safe and triggers an immune response, according to a study published in the medical journal?The Lancet.

pharmaceutical /?fɑ?m??su?t?kl/ ?/??sju??/ ?[ only before noun ] 制藥的；配藥的；賣藥的

The Lancet：柳葉刀雜志

“It is good news”, said Dr. Michael Ryan, Executive Director of WHO’s Health Emergencies Programme, though he cautioned that “the data is very new”.

Dr. Ryan said the vaccine was given to 1,000 healthy adults aged 18 to 55 years. None appeared to suffer any serious adverse effects, other than chills, muscle aches and headaches, which were expected.

“But again, there is a long way to go”, he said. “These are phase one studies. We now need to move into large-scale, real-world trials, but it is good to see more data and more products moving into this very important phase of vaccine discovery.”

Dr. Ryan reported that 23 COVID-19 candidate vaccines are currently in clinical development.

原文鏈接：https://news.un.org/en/story/2020/07/1068681